CLASS III Drug recall · Reported 13 Dec 2023 · FDA Enforcement Report

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine recalled

Right Value Drug Stores is recalling LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), distributed nationwide in the US. The recall was initiated on 9 Nov 2023 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot#: 09202023@7, Exp 03/18/2024
Quantity recalled190 syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0140-2024
FDA event ID
93316
Recalling firm
Right Value Drug Stores, Irving, TX
Classification
Class III
Status
Terminated
Recall initiated
9 Nov 2023
FDA classified
6 Dec 2023
Reported
13 Dec 2023
Type
Voluntary: Firm initiated
Reason category
Packaging Defects
Drug class
Pain Medication

Timeline

9 Nov 2023Recall initiated by company
6 Dec 2023Classified by FDA+27 days
13 Dec 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Product Mix-up: Incorrect Product Formulation

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

Where it was distributed

USA Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Product Mix-up: Incorrect Product Formulation

Which lots are affected?

Lot#: 09202023@7, Exp 03/18/2024

Where was it sold?

USA Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Right Value Drug Stores

All 7